Bio-Rad Laboratories Inc. Class A (BIO)

Bio-Rad Laboratories Inc. Class A (BIO $293.70)
- $293.70 Cap: $8.08B
- View BIO Profile
- View Questions on BIO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $109.30)
- $109.30 P/E (TTM): 13.71X Cap: $190.05B
- View ABT Profile
- View Questions on ABT
Danaher Corporation (DHR $218.89)
- $218.89 P/E (TTM): 45.04X Cap: $154.61B
- View DHR Profile
- View Questions on DHR
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.74X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $369.56)
- $369.56 P/E (TTM): 48.56X Cap: $141.32B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $578.61)
- $578.61 P/E (TTM): 33.43X Cap: $217.38B
- View TMO Profile
- View Questions on TMO
UnitedHealth Group Incorporated (DE) (UNH $286.93)
- $286.93 P/E (TTM): 14.97X Cap: $259.91B
- View UNH Profile
- View Questions on UNH
Zoetis Inc. Class A (ZTS $124.82)
- $124.82 P/E (TTM): 21.01X Cap: $55B
- View ZTS Profile
- View Questions on ZTS
DexCom Inc. (DXCM $73.04)
- $73.04 P/E (TTM): 40.8X Cap: $28.48B
- View DXCM Profile
- View Questions on DXCM
STERIS plc (Ireland) (STE $262.60)
- $262.60 P/E (TTM): 37.73X Cap: $25.77B
- View STE Profile
- View Questions on STE
Bio-Rad Laboratories Inc. Class A (BIO $293.70)
- $293.70 Cap: $8.08B
- View BIO Profile
- View Questions on BIO

Q: Hello,

I'm looking to buy 4 or 5 US medical stocks for a long-term hold (5+ years) with an above-average level of risk tolerance.

Could you please rank the stocks I've listed, and indicate if there are better choices.

Thank you!

Read Answer Asked by Barbara on March 15, 2022